Professor, Pathology, Ohio State University College of Medicine

Pathology

Michael Bissell works in the field of Pathology. He attended Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. Michael G. Bissell is a published MD. He published 96 publications, including: 'Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of chronic glomerular disease.'

Publications

---

• Spot PC ratio estimates of 24-hour proteinuria are more unreliable in lupus nephritis than in other forms of chronic glomerular disease.
• Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloi...
• Studying critical values: adverse event identification following a critical laboratory values study at the ohio state university medical center.
• Beware of unwritten institutional policies.
• Answering questions from the public.
• There is no such thing as free pizza.
• Hostility and pain are related to inflammation in older adults.
• Should a medical license be revoked because of research fraud?
• Employee's well-being a manager's responsibility.
• Newborn screening: speaking out on state program.
• A potential time bomb.
• Losing health insurance coverage: unjust or unfortunate?
• Prototype integration of protein electrophoresis laboratory results in an information warehouse to improve workflow and data analysis.
• Informing patients about violations of confidentiality.
• The medical review officer and conflicts of interest.
• Firing employees who smoke.
• Blowing the whistle on poor laboratory performances, part 2. To report or to not report.
• Blowing the whistle on poor laboratory performances.
• "Bad blood" in the cytology lab.
• Information systems and human error in the lab.
• Learning from adverse events in clinical studies: a proposal.
• Reporting lab results directly to the patient.
• Using blood from autopsy cases for research.
• A past incorrect pathologic diagnosis.
• Case studies in ethics. Screening archived specimens.
• Advertising genetic testing for breast cancer.
• Case studies in ethics. DAT and DTC advertising.
• Managing personnel: the importance of procedural fairness.
• Revealing the identity of sperm bank donors.
• Case studies in ethics 1993-2003: a 10-year retrospective.
• When a physician goes beyond needlestick protocol.
• The institutional review board and investigator conflicts of interest.
• Questioning proposed practices: individual responsibility in organizations.
• Case studies in ethics. The ethics of expert scientific commentary.
• Socially sensitive research.
• Correcting technically incorrect information.
• Case studies in ethics. Manager in the middle.
• Infectious diseases, confidentiality, and research ethics.
• Ethics and the clinical laboratory. Part III. Laboratory quality and economic necessity: values in collision.
• Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares.
• The challenges and opportunities of laboratory regionalization.
• The temporal fate of drugs in decomposing porcine tissue.
• Whither outcomes?
• Health care reform and the clinical laboratory.
• CLMA research initiative: moving into the 21st century with leadership in knowledge. CLMA Research Advisory Committee.
• Ensuring universal access to quality laboratory services: CLMA White Paper. National Affairs Committee, Clinical Laboratory Management Association.
• Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications.
• Leukocytoreduction for acute leukemia.
• The laboratory's role in outcome assessment.
• Empowering patients with point-of-care testing.
• Ethics and the clinical laboratory. Part I: How ethical dilemmas induce stress.
• A rapid test for the diagnosis of thrombotic thrombocytopenic purpura using surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF)-mass spectrometry.
• Leveling the playing field. The economics of robotics in the hospital clinical lab.
• Accuracy of portable blood glucose monitoring. Effect of glucose level and prandial state.
• Ethics and professionalism: the case of genetic testing.
• Clinical pathways: Part I. Panel discussion.
• Clinical pathways: Part 2.
• The clinical services manager: a curriculum for the 21st century.
• Uninvited intervention in a patient rights issue.
• Ethics and the clinical laboratory. Part II. What has happened to patient confidentiality?
• Point-of-care testing at the millennium.
• Cost-effective purchasing and the responsible manager.
• Research ethics and new diagnostic technologies.
• Community health outcomes and the public good.
• Assessing the cost of cost reduction.
• Whistleblowing.
• Purchasing ethics and confidential bids.
• Integrity in faculty recruiting.
• The ethics of billing.
• Is the customer always right?
• When a health-care plan does not cover an ordered test.
• Ethics and race-based home care assignments.
• An older employee's poor performance.
• Reporting panic values in the middle of the night.
• Profit or service.
• The troubled phlebotomist: training new employees in an ethical organization.
• When mistakes happen.
• To err is human: learning opportunities for the clinical laboratory.
• Confidentiality and HIV screening following employee needlestick.
• Case studies in ethics. Modifying physician behavior.
• Consent and confidentiality in genetic research.
• Case studies in ethics. Reporting test results.
• Ethics and the future of health care.
• HIV reporting.
• Restrictions on the future employment of employees.
• Celebrities and confidentiality.
• Expediency in proficiency testing.
• Protecting against the disgruntled employee.
• Case studies in ethics. A case of overutilization.
• Case studies in ethics. A substance-abusing manager.
• Case studies in ethics. The integrity of academic research.
• Telling the unwelcome truth.
• Challenging disease gene patent holders.
• Genetic test results and information systems.
• Fraud fallout: where the buck stops.

Schools

---

• Stanford University School Of Medicine

Doctors Specialties

---

• Clinical Pathology
• Pathology

Accepted Insurances

---

Education

---

• Stanford University
• Stanford University School of Medicine

Hospital

---

• Ohio State University Wexner Medical Center

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Peter Accetta, MD, FAAD This Doctor is OpenDoctor Recommended.
	Dr. Amy S. Gewirtz, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael I. Maymind, MD
	Dr. Stephen F. Moore, MD This Doctor is OpenDoctor Recommended.
	Dr. Randall E. Harris, MD
	Dr. Leo A. Niemeier, MD This Doctor is OpenDoctor Recommended.
	Dr. Vinay Prasad, MD This Doctor is OpenDoctor Recommended.
	Dr. Gary H. Tozbikian, MD This Doctor is OpenDoctor Recommended.
	Dr. Sura M. Al-Rawabdeh, MD
	Dr. Aharon G. Freud, MD
	Dr. Stephen M. Smith, MD
	Dr. Haifeng M. Wu, MD This Doctor is OpenDoctor Recommended.
	Dr. Weiqiang Zhao, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog